Nadira Frescaline,Andrew Beckett,Michael C Reade
Nadira Frescaline
Nicholas Wong,David Barnes,James Hartley et al.
Nicholas Wong et al.
Na&#x;ama Carlin
Na&#x;ama Carlin
Jean-Yves Blay
Jean-Yves Blay
Sophie Cousins
Sophie Cousins
Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial [0.03%]
皮米妥尼布与安慰剂治疗滑液肉瘤（MANEUVER）：一项国际性、随机化、双盲、安慰剂对照的III期临床试验
Hairong Xu,Xiaohui Niu,Vinod Ravi et al.
Hairong Xu et al.
Background: Tenosynovial giant cell tumour (TGCT) is a rare, locally aggressive neoplasm that affects otherwise healthy adults. There are few systemic treatment options, highlighting an unmet need. We report the results o...
Changes in paracetamol and leucovorin use after a White House briefing [0.03%]
白宫简报会后对对乙酰氨基酚和左亚叶酸的使用变化
Jeremy Samuel Faust,Michael L Barnett
Jeremy Samuel Faust
Stephen Vickers Boyden [0.03%]
史蒂芬·维克尔斯·博伊登
Andrew Green
Andrew Green
Effect of baxdrostat on ambulatory blood pressure in patients with resistant hypertension (Bax24): a phase 3, randomised, double-blind, placebo-controlled trial [0.03%]
巴索 drostat 对难治性高血压患者动态血压的影响（Bax24）：一项随机、双盲、安慰剂对照III期临床试验
Michel Azizi,Jenifer M Brown,Jamie P Dwyer et al.
Michel Azizi et al.
Background: Aldosterone dysregulation is an important contributor in the pathogenesis of hard-to-control hypertension. We aimed to assess the effect of baxdrostat, a selective aldosterone synthase inhibitor, on ambulatory...
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial [0.03%]
早期乳腺癌低分割根治性放疗5年结果：HypoG-01（UNICANCER）研究——一项法国多中心、随机、非劣效性III期开放标签对照试验
Sofia Rivera,Robabeh Ghodssighassemabadi,Guillaume Auzac et al.
Sofia Rivera et al.
Background: Hypofractionated radiotherapy is standard for whole-breast radiotherapy, but 50 Gy in 25 fractions (5-week radiotherapy) is still standard in many countries when nodal radiotherapy is needed for morbidity conc...